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iliac PTA and stent data primarily reflect the treatment of unilateral (iliac) disease, with lesions
amenable to these modalities.
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D4.7 Introduction to Preferred Therapeutic Options
The decision about what type of revascularization to recommend ideally should be made by a
multidisciplinary team. Important issues that may influence the recommended decision are:
• lesion morphology
• risk of surgery for that particular patient
• previous procedures (ie, bypass or angioplasty)
• patient's life expectancy
• local expertise and experience with particular surgical or endovascular procedures
In general, endovascular procedures are safer and require shorter hospitalization compared with
surgical procedures. Durability of these endovascular procedures is, however, less well estab-
lished. For most lesions, there is no direct evidence comparing the results of endovascular or
surgical treatment in a controlled, prospective, randomized study.
The system used for preferred therapeutic options has been detailed (see B 4.3,
Endovascular Procedures for Intermittent Claudication, p 897). Lesions are defined and
then placed in four groups, each group usually being treated in a similar way. The two
extremes are type A lesions, in which endovascular approach is the treatment of choice,
and type D lesions, in which surgery is the treatment of choice. In between these two
groups are types B and C lesions, in which no firm recommendations can be made about
the preferred interventional option. However, endovascular treatment is more commonly
used in type B lesions and surgical treatment is more commonly used in type C lesions.
There is insufficient solid evidence to make any firm recommendations, particularly in the
case of types B and C. Most patients with CLI have multilevel disease, and it may be
appropriate to use different techniques for different lesions.
D 4.7.1 Aortoiliac Disease-Preferred Therapeutic Options
The following and other similarly set out recommendations merely consider tile probable rela-
tive merits of surgical and endovascular treatment, on the assumption that intervention is desir-
able. It is therefore identical to Recommendation 31 (p 598). The final choice of intervention,
particularly for category 2 and 3 lesions, will of course depend on a number of other considera-
tions, such as the patient's overall health, the severity of the local lesion, etc.
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&commendation 31: Morphological stratification Q,filiac lesions
TASC TypeA iliac lesions:
1. Single stenosis <3em ofthe CIA or EIA (unilateraljbilateral)
TASC Type B iliac lesions:
2. Single stenosis 3-10 em in length, not extending into the common. femora; artery
(CPA)
3. Total of two stenoses <Scm long in the CIA and/or EIA and not extending into
the CFA
4. Unilateral CIA occlusion
TASC Type C iliac lesions:
5.Bilateral 5-10-cm-long stenoses of the CIA and/or EIA, not extending into the CFA
6. Unilateral EIA occlusion not extending into the CPA
7. Unilateral BIA stenosis extending into the CPA
8. Bilateral CIA occlusion
TASC Type D iliac lesions:
9.Diffuse, multiple unilateral stenoses involving the CIA, EIA, and CPA (usually
>1Oem)
10. Unilateral occlusion involving both the CIA and BIA
11. Bilateral EIA occlusions
12. Diffuse disease involving the aorta. and both iliac arteries
13. Iliac stenoses in a patient with an abdominal aortic aneurysm or other lesion
requiring aortic or iliac surgery
Abbreviations: CIA, common iliac artery;BIA, external iliac artery; CFA, common femoral artery.
Repeated from p 598
Recommendation 32: Treatment ofchoicefer TASC type A and D aortoiliac lesions
Bndovascular procedure is the treatment ofchoice for type A lesions and surgery is the proce-
dure ofchoicefor type D lesions.
Repeated from p 598
Critical Issue 10: Treatment ofTASC type Band C lesions
More evidence is needed to make any firm recommendations about the best treatment for
TASC typesBand C lesions. ,.
*CIRSE dissentitlg ~pi1iion:
Currently endovascular treatment is morecommonly llScd for type B and C lesions, but moreevidence is Ileeded to make
anyfirm recommendations abo»:besttreatment.
Reason for dissentiua l1J!iniorr Due to technicaldevelopments, type C lesions ofiliac and femoral arteries can he treated by
mdol'Mclllarmeans with a reasonable technicalS1lCCC!S rate (for references, see B 4.3), Therefore, ClRSE believes that ill
elitliml practice these lesions m'e more commonlytreated byendovasnlar techniques, althollghscientific evidenc« ofallY
Stlperi~rity overvascular Stlrgery is IlIcking.
D 4.7.2 Combined Surgical and Endovascular Procedures
This discussion primarily concerns the choice between open surgical reconstruction and
endovascular procedures and is directed toward proximal revascularization. The common occur-
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renee of multilevel disease in Cl.I patients has already been alluded to and discussed in terms of
the need for concomitant distal bypass. However, combinations of endovascular and surgical
procedures are increasingly being employed. Combined endovascular/surgical procedures have
had some success in this regard. In considering the approach to a combined procedure, either
concurrently in the operating room or sequentially in the angiography suite with early subse-
quent bypass, each lesion must be considered on its own merit. Iliac artery dilatation to improve
inflow for a cross-femoral graft has been reported to be successful in carefully selected
patients.l-s Those patients with pressure gradients across aortoiliac stenoses should have these
corrected before construction of a distal bypass graft.
For suitable lesions, balloon angioplasty, performed either intraoperatively or preoperatively, pro-
vides adequate inflow to maintain the distal reconstruction. The quality of the endovascular and
surgical components of the technique must not be compromised by skills and training of the
individual performing either part of the procedure. Also, in the absence of sufficient length of
ideal conduit tor a distal bypass, balloon angioplasty may remove a discrete lesion distally, per-
mitting longer-term patency of an otherwise compromised graft. The determination of combin-
ing or performing the procedures sequentially will be determined by local circumstances.
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D 4.8 Infrainguinal Disease-Surgical Treatment
The main guiding principles behind surgical reconstruction are to bypass into the best available
outflow vessel possible regardless of the anatomic level and to construct the bypass graft with
autogenous vein. Further explanation and exceptions to these principles are discussed in the fol-
lowing sections. The issue of above-knee femoropopliteal bypass grafting has been addressed earli-
er (see B 4.4, Surgery for Intermittent Claudication, p SI13). When a bypass graft is constructed
to an outflow artery below the knee, autogenous tissue is accepted as the preferred conduit.
D 4.8.1 Inflow
Before reconstruction of infrainguinal PAD, the surgeon must ensure adequate inflow to the
groin level or site of proximal anastomosis (see also Recommendation 88, p S210). The
common femoral artery or an inflow graft is the usually accepted origin of a femoral distal
bypass graft. A number of authors have reviewed experience with more distal take-off of
bypass grafts (profunda, SFA, popliteal) and have found that in appropriately chosen individ-
uals there is no compromise to the bypass. 1,2,3 For example, a stenosis of20% or more in the
native superficial femoral artery proximal to a graft origin has been correlated with eventual
graft failure.! Because atherosclerosis is a generalized and in many cases progressive disease,
distal origin bypass grafts should be undertaken only when inflow to that level is uncornpro-
mised. This issue is of some importance when alternative (and presumably shorter) segments
of vein must be used for bypass grafts.
Recommendation 89: Inflow artery for femorodistal bypass
Any artery, regardless of level (ie, not only the common femoral artery), may serve as an
inflow artery for a distal bypass provided that flow to mat artery and the origin of the
graft is uncompromised.
